NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Cash & Equivalents Growth (1y) (2021 - 2025)

Analysis

NeuroSense Therapeutics (NRSN) Cash & Equivalents Growth (1y) (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 74.25%
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -38.20%
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 23.56%
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 23.05%
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 34.71%
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 71.81%
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 53.39%
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -53.42%
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - -95.09%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -95.09%
Jun 30, 2025 -44.87%
Dec 31, 2024 -4.66%
Sep 30, 2024 -92.77%
Jun 30, 2024 -82.96%
Mar 31, 2024 -45.92%
Dec 31, 2023 0.00%
Sep 30, 2023 7.89%
Jun 30, 2023 63.00%
Mar 31, 2023 -84.44%
Dec 31, 2022 406.87%
Dec 31, 2021 0.00%
API Access

NeuroSense Therapeutics Cash & Equivalents Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents-growth-1y&ticker=NRSN&period=max&api_key=YOUR_API_KEY